BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 6513748)

  • 1. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
    Magdon E; Schröder E
    Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modification of the action of ionizing radiation on cells of transplantable tumors by administering xanthobine].
    Volchkov VA; Mikhaĭlova NIa; Klimovich VB
    Radiobiologiia; 1985; 25(1):112-4. PubMed ID: 3975364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
    Rockwell S; Irvin CG; Nierenburg M
    Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 6. [The radiation sensitizing activity of metronidazole and iso-metronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole)].
    Proskurjakov SJ; Smoryzanova OA; Rjabcenko NI; Dedenkov AN
    Radiobiol Radiother (Berl); 1990; 31(6):531-6. PubMed ID: 2101458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 4-nitroimidazole (iso-metronidazole) on the radiation-induced growth retardation and therapeutic quotient of transplanted tumors].
    Magdon E
    Radiobiol Radiother (Berl); 1985; 26(3):351-8. PubMed ID: 4059521
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
    Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
    Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the radiosensitizing action of metronidazole administered orally and locally].
    Volchkov VA; Rudenko IIa; Zharinov GM; Khanson KP; Kholin VV
    Radiobiologiia; 1988; 28(1):128-30. PubMed ID: 3344324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metronidazole: basic experimental results and clinical prospects].
    Pelevina II; Voronina SS; Karakulov RK; Potapov SL; Dronova LM
    Med Radiol (Mosk); 1984 Feb; 29(2):10-20. PubMed ID: 6700386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioprotective phenomena in murine tumors induced by radiosensitizers at high dose levels].
    Shibamoto Y; Ono K; Takahashi M; Abe M; Hori H; Shibata T; Inayana S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 May; 46(5):725-7. PubMed ID: 3763390
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM; Lemmon MJ
    Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement of the antitumor effect of ionizing radiations in the combined use of metronidazole and induced hyperglycemia].
    Vinskaia NP; Voloshina EA; Vygodskaia AL; Iarmonenko SP
    Med Radiol (Mosk); 1984 Dec; 29(12):13-7. PubMed ID: 6513744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibility of lowering the dose of metronidazole during the irradiation of tumors using subsequent artificial hyperglycemia].
    Vinskaia NP; Voloshina EA; Kozin SV
    Med Radiol (Mosk); 1989 Oct; 34(10):61-5. PubMed ID: 2811633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of nitrobenzimidazoles as hypoxic cell radiosensitizers.
    Wright J; Frank LR; Bush D; Harrison GH
    Radiat Res; 1983 Jul; 95(1):187-96. PubMed ID: 6348867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fractionated radiation treatment combined with hyperthermia in transplantable adenocarcinoma of the mouse (author's transl)].
    von Szczepanski L; Trott KR
    Strahlentherapie; 1978 Sep; 154(9):653-5. PubMed ID: 684788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.